Development of Multifunctional Drug and Gene Delivery Systems (R01)

The summary for the Development of Multifunctional Drug and Gene Delivery Systems (R01) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Development of Multifunctional Drug and Gene Delivery Systems (R01)
	CFDA Number:	93.394
	CFDA Description:	Cancer Detection and Diagnosis Research
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Education Health
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	PAR-10-048
	Document Type:	Grants Notice
	Funding Instrument Type:	Grant
	Posted Date:	Dec 07, 2009
	Creation Date:	Dec 07, 2009
	Original Closing Date for Applications:	Jan 07, 2013
	Current Closing Date for Applications:	Jan 07, 2013
	Archive Date:	Feb 07, 2013
	Expected Number of Awards:	Information not provided
	Estimated Total Program Funding:	Information not provided
	Federal Grant Award Ceiling:	Information not provided
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Grant Description: Purpose. This Funding Opportunity Announcement (FOA), issued by the National Institute of Biomedical Imaging and Bioengineering and the National Heart, Lung, and Blood Institute, National Institutes of Health, encourages Research Project Grant (R01) applications from institutions/organizations that propose the engineering of novel, multifunctional drug and gene delivery systems that can target therapies to particular cells and intracellular compartments and can monitor delivery and determine therapeutic efficacy through the integration of advanced imaging and/or sensing technologies into the delivery system. Applications should propose to develop at least one prototype system by the end of the project period. Applications that are submitted to this FOA should include investigators from both the drug/gene delivery and imaging fields. Applicants are strongly encouraged to use the Multi-PD/PI model to meet the imaging and drug/gene delivery expertise. Mechanism of Support. This FOA utilizes the NIH R01 research grant award mechanism. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/par-10-048.html
Grant Announcement Contact: NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants: • Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R21); • Strategic Partnering to Evaluate Cancer Signatures [SPECS II] (U01); • Quantitative Imaging for Evaluation of Responses to Cancer Therapies (U01); • SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technolog...; • Opportunity RFA-AI-10-030; • Image-Guided Cancer Interventions (STTR [R41/R42]); • An SBIR Initiative for Image-Guided Cancer Interventions (R43/R44); • IN VIVO CANCER IMAGING EXPLORATORY/DEVELOPMENTAL GRANTS; • Exploratory Studies in Cancer Detection, Diagnosis, and Prognosis; • PHASED APPLICATION AWARDS IN CANCER PROGNOSIS AND PREDICTION